Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sanjay Awasthi

Showing results (41-50 of 152) with videos related to

Pageof 16
Sort By:
Current Drug Metabolism|May 17, 2007
The non-ABC drug transporter RLIP76 (RALBP-1) plays a major role in the mechanisms of drug resistanceYogesh C Awasthi, Rajendra Sharma, Sushma Yadav, et al.
Biochemical Pharmacology|December 17, 2008
Regression of prostate cancer xenografts by RLIP76 depletionSharad S Singhal, Cherice Roth, Kathryn Leake, et al.
Cancer Letters|January 27, 2019
RLIP inhibition suppresses breast-to-lung metastasisJyotsana Singhal, Shireen Chikara, David Horne, et al.
Carcinogenesis|May 20, 2020
Targeting RLIP with CRISPR/Cas9 controls tumor growthJyotsana Singhal, Shireen Chikara, David Horne, et al.
Carcinogenesis|February 24, 2021
RLIP depletion induces apoptosis associated with inhibition of JAK2/STAT3 signaling in melanoma cellsSharad S Singhal, Atish Mohanty, Prakash Kulkarni, et al.
Cancer Letters|September 18, 2018
Metastasis of breast tumor cells to brain is suppressed by targeting RLIP alone and in combination with 2'-HydroxyflavanoneJyotsana Singhal, Preeti Singhal, David Horne, et al.
Molecular Carcinogenesis|April 23, 2019
Synergistic efficacy of RLIP inhibition and 2'-hydroxyflavanone against DMBA-induced mammary carcinogenesis in SENCAR miceSharad S Singhal, David Horne, Jyotsana Singhal, et al.
Cancer Prevention Research (Philadelphia, Pa.)|December 17, 2011
Didymin induces apoptosis by inhibiting N-Myc and upregulating RKIP in neuroblastomaJyotsana Singhal, Lokesh Dalasanur Nagaprashantha, Rit Vatsyayan, et al.
Breast Cancer Research : BCR|September 8, 2019
Prexasertib treatment induces homologous recombination deficiency and synergizes with olaparib in triple-negative breast cancer cellsChinnadurai Mani, Shirisha Jonnalagadda, Jojireddy Lingareddy, et al.
Molecular Carcinogenesis|August 24, 2018
2'-Hydroxyflavanone inhibits in vitro and in vivo growth of breast cancer cells by targeting RLIP76Jyotsana Singhal, Shireen Chikara, David Horne, et al.
Pageof 16

Showing results (41-50 of 152) with videos related to

Sort By:
Pageof 16
Current Drug Metabolism|May 17, 2007
The non-ABC drug transporter RLIP76 (RALBP-1) plays a major role in the mechanisms of drug resistanceYogesh C Awasthi, Rajendra Sharma, Sushma Yadav, et al.
Biochemical Pharmacology|December 17, 2008
Regression of prostate cancer xenografts by RLIP76 depletionSharad S Singhal, Cherice Roth, Kathryn Leake, et al.
Cancer Letters|January 27, 2019
RLIP inhibition suppresses breast-to-lung metastasisJyotsana Singhal, Shireen Chikara, David Horne, et al.
Carcinogenesis|May 20, 2020
Targeting RLIP with CRISPR/Cas9 controls tumor growthJyotsana Singhal, Shireen Chikara, David Horne, et al.
Carcinogenesis|February 24, 2021
RLIP depletion induces apoptosis associated with inhibition of JAK2/STAT3 signaling in melanoma cellsSharad S Singhal, Atish Mohanty, Prakash Kulkarni, et al.
Cancer Letters|September 18, 2018
Metastasis of breast tumor cells to brain is suppressed by targeting RLIP alone and in combination with 2'-HydroxyflavanoneJyotsana Singhal, Preeti Singhal, David Horne, et al.
Molecular Carcinogenesis|April 23, 2019
Synergistic efficacy of RLIP inhibition and 2'-hydroxyflavanone against DMBA-induced mammary carcinogenesis in SENCAR miceSharad S Singhal, David Horne, Jyotsana Singhal, et al.
Cancer Prevention Research (Philadelphia, Pa.)|December 17, 2011
Didymin induces apoptosis by inhibiting N-Myc and upregulating RKIP in neuroblastomaJyotsana Singhal, Lokesh Dalasanur Nagaprashantha, Rit Vatsyayan, et al.
Breast Cancer Research : BCR|September 8, 2019
Prexasertib treatment induces homologous recombination deficiency and synergizes with olaparib in triple-negative breast cancer cellsChinnadurai Mani, Shirisha Jonnalagadda, Jojireddy Lingareddy, et al.
Molecular Carcinogenesis|August 24, 2018
2'-Hydroxyflavanone inhibits in vitro and in vivo growth of breast cancer cells by targeting RLIP76Jyotsana Singhal, Shireen Chikara, David Horne, et al.
Pageof 16